Cargando…

Pharmacokinetics of micafungin in adult patients with invasive candidiasis and candidaemia

Detalles Bibliográficos
Autores principales:	Kuse, ER, Demeyer, I, Undre, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088393/ http://dx.doi.org/10.1186/cc6243

Ejemplares similares

Pharmacokinetics of micafungin in patients with severe burn injuries
por: Sasaki, J, et al.
Publicado: (2012)

Pharmacokinetics of micafungin in patients with severe burn injuries
por: Sasaki, J, et al.
Publicado: (2011)

Pharmacokinetics of micafungin in subjects with severe hepatic dysfunction
por: Undre, Nasrullah, et al.
Publicado: (2014)

Impact of early catheter removal during treatment of invasive candidiasis: analysis from two phase 3 micafungin trials
por: Nucci, M, et al.
Publicado: (2009)

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
por: Wiederhold, Nathan P, et al.
Publicado: (2009)

Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients
por: Ruhnke, M, et al.
Publicado: (2012)

Micafungin for the treatment of pediatric invasive fungal infections
por: Arrieta, A, et al.
Publicado: (2009)

Cost-effectiveness analysis of anidulafungin in the treatment of candidaemia
por: Auzinger, G, et al.
Publicado: (2013)

Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis
por: Auzinger, Georg, et al.
Publicado: (2015)

Pooled analysis of safety for micafungin
por: Cornely, OA, et al.
Publicado: (2008)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature
por: Glöckner, A
Publicado: (2011)

Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study
por: van der Geest, Patrick J., et al.
Publicado: (2016)

Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients
por: Ruhnke, M, et al.
Publicado: (2011)

Pharmacokinetics of Micafungin in Critically Ill Patients
por: Gastine, Silke, et al.
Publicado: (2019)

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin
por: Wasmann, Roeland E., et al.
Publicado: (2017)

Demographic and outcome differences in ICU patients with proven invasive candidiasis, possible invasive candidiasis and probable candida colonization: analysis of the EPIC II study population
por: Kett, D, et al.
Publicado: (2011)

Characterizing Safety and Clinical Outcomes Associated with High-Dose Micafungin Utilization in Patients with Proven Invasive Candidiasis
por: Grant, Victoria C., et al.
Publicado: (2022)

A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis
por: Benjamin, Daniel K., et al.
Publicado: (2018)

Micafungin concentrations 100 mg daily in plasma and burn eschars in patients with severe burn injuries
por: Agrifoglio, A, et al.
Publicado: (2015)

Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study
por: Viscoli, Claudio, et al.
Publicado: (2014)

P28 Rezafungin efficacy and safety in immunocompromised patients: sub-analyses of the Phase 3 trial in treatment of candidaemia and invasive candidiasis
por: Sandison, Taylor, et al.
Publicado: (2023)

Toll like receptor 1 polymorphisms and susceptibility to invasive candidiasis
por: Plantinga, T, et al.
Publicado: (2009)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs - review of the literature
por: Wilke, MH
Publicado: (2011)

Species distribution and antifungal susceptibility of Candida species causing candidaemia in a Thai university hospital during year 2006-2010
por: Ankkananukul, K, et al.
Publicado: (2011)

Exposure–Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials
por: Kovanda, Laura L., et al.
Publicado: (2018)

594. Micafungin Prophylaxis in Acute Myeloid Leukemia Adult Patients Undergoing Induction Chemotherapy
por: Ross, Justine Abella, et al.
Publicado: (2021)

P27 Rezafungin treatment of candidaemia and invasive candidiasis: outcomes stratified by baseline renal function—analysis of the Phase 2 + Phase 3 trials
por: Sandison, Taylor, et al.
Publicado: (2023)

1167. Got Micafungin? The Incidence of Fungemia in Patients with Septic Shock
por: Piche, Mackenzie, et al.
Publicado: (2020)

A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis
por: Kohno, S., et al.
Publicado: (2012)

Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients
por: Martial, Lisa C., et al.
Publicado: (2017)

Epidemiological cohort study of systemic antifungal therapy for suspected or confirmed invasive candidiasis in the ICU: the Amarcand2 study
por: Constantin, J, et al.
Publicado: (2015)

Candidaemia and cancer: patients are not all the same
por: Pasqualotto, Alessandro Comarú, et al.
Publicado: (2006)

Biofilm profile of candidaemia isolates
por: Sheena, M.S., et al.
Publicado: (2023)

61. Evaluation of the Impact of a Micafungin Time-Out Protocol for Hospitalized Patients
por: Williams, Kelsey N, et al.
Publicado: (2020)

Evaluation of Candida peritonitis with underlying peritoneal fibrosis and efficacy of micafungin in murine models of intra-abdominal candidiasis
por: Ashizawa, Nobuyuki, et al.
Publicado: (2019)

P29 Outcomes by baseline pathogen and susceptibility in the ReSTORE Phase 3 trial of rezafungin once weekly compared with caspofungin once daily in patients with candidaemia and/or invasive candidiasis
por: Thompson, G R, et al.
Publicado: (2023)

Mortality in patients with early- or late-onset candidaemia
por: De Rosa, Francesco Giuseppe, et al.
Publicado: (2013)

Pharmacokinetics of micafungin in patients treated with extracorporeal membrane oxygenation: an observational prospective study
por: López-Sánchez, Marta, et al.
Publicado: (2020)

Differences between intraabdominal candidiasis in regular wards versus intensive care unit
por: Lagunes, L, et al.
Publicado: (2015)

Candidaemia in a tertiary hospital in Nigeria
por: Oladele, Rita O., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d4itgh2bv53nlq5gg2972mspai